S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
NYSE:CNMD

CONMED - CNMD Stock Forecast, Price & News

$87.00
+1.18 (+1.37%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$85.68
$87.19
50-Day Range
N/A
52-Week Range
$71.09
$155.51
Volume
299,909 shs
Average Volume
414,609 shs
Market Capitalization
$2.65 billion
P/E Ratio
N/A
Dividend Yield
0.93%
Price Target
$106.00

CONMED MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
21.8% Upside
$106.00 Price Target
Short Interest
Bearish
11.22% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.18mentions of CONMED in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
5.96%
From $3.19 to $3.38 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.72 out of 5 stars

Medical Sector

838th out of 1,027 stocks

Electromedical Equipment Industry

20th out of 23 stocks

CNMD stock logo

About CONMED (NYSE:CNMD) Stock

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Stock News Headlines

Head-To-Head Review: CONMED (NYSE:CNMD) & InMode (NASDAQ:INMD)
Critical Review: CONMED (CNMD) & The Competition
CONMED Corporation Announces Quarterly Cash Dividend
Comparing Masimo (NASDAQ:MASI) & CONMED (NYSE:CNMD)
Analyzing CONMED (NYSE:CNMD) and Medtronic (NYSE:MDT)
CONMED (CNMD) & Its Rivals Head-To-Head Contrast
Critical Survey: CONMED (CNMD) versus The Competition
Contrasting CONMED (CNMD) & The Competition
Head to Head Review: CONMED (CNMD) & Its Competitors
CONMED (CNMD) and Its Peers Financial Contrast
Analyzing CONMED (CNMD) and The Competition
Critical Analysis: CONMED (CNMD) & Its Peers
Financial Survey: CONMED (CNMD) & Its Peers
Why Is Conmed (CNMD) Up 6.8% Since Last Earnings Report?
CONMED Corp. Withdraws Full-year Guidance
See More Headlines
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Company Calendar

Last Earnings
10/26/2022
Today
12/07/2022
Ex-Dividend for 1/5 Dividend
12/15/2022
Fiscal Year End
12/31/2022
Dividend Payable
1/05/2023
Next Earnings (Estimated)
1/25/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Employees
3,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$106.00
High Stock Price Forecast
$106.00
Low Stock Price Forecast
$106.00
Forecasted Upside/Downside
+21.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$62.54 million
Pretax Margin
-2.87%

Debt

Sales & Book Value

Annual Sales
$1.01 billion
Cash Flow
$6.38 per share
Book Value
$26.85 per share

Miscellaneous

Free Float
28,988,000
Market Cap
$2.65 billion
Optionable
Optionable
Beta
1.41

Key Executives

  • Mr. Curt R. HartmanMr. Curt R. Hartman (Age 58)
    Chairman, CEO & Pres
    Comp: $2M
  • Mr. Todd W. GarnerMr. Todd W. Garner (Age 53)
    Exec. VP & CFO
    Comp: $908.45k
  • Mr. Daniel S. Jonas Esq. (Age 58)
    Exec. VP of Legal Affairs, Gen. Counsel & Sec.
    Comp: $646.48k
  • Mr. Patrick J. Beyer (Age 56)
    Pres of International & Global Orthopedics
    Comp: $1.24M
  • Mr. Stanley W. Peters IIIMr. Stanley W. Peters III (Age 47)
    Pres of Advanced Surgical & Advanced Endoscopic Technologies
    Comp: $681.04k
  • Mr. Peter K. Shagory (Age 53)
    Exec. VP of Strategy & Corp. Devel.
  • Ms. Heather L. Cohen (Age 49)
    Exec. VP of HR
  • Mr. John E. KennedyMr. John E. Kennedy (Age 64)
    Special Advisor
  • Ms. Shanna L. Cotti-Osmanski (Age 45)
    Exec. VP of Information Technology & CIO
  • Mr. David R. Murray (Age 74)
    Pres of ConMed Electrosurgery













CNMD Stock - Frequently Asked Questions

Should I buy or sell CONMED stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CNMD shares.
View CNMD analyst ratings
or view top-rated stocks.

What is CONMED's stock price forecast for 2023?

1 Wall Street analysts have issued 1 year price targets for CONMED's stock. Their CNMD share price forecasts range from $106.00 to $106.00. On average, they predict the company's share price to reach $106.00 in the next twelve months. This suggests a possible upside of 21.8% from the stock's current price.
View analysts price targets for CNMD
or view top-rated stocks among Wall Street analysts.

How have CNMD shares performed in 2022?

CONMED's stock was trading at $79.06 on January 1st, 2022. Since then, CNMD stock has increased by 10.0% and is now trading at $87.00.
View the best growth stocks for 2022 here
.

Are investors shorting CONMED?

CONMED saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 3,300,000 shares, an increase of 5.1% from the October 15th total of 3,140,000 shares. Based on an average daily volume of 364,400 shares, the short-interest ratio is currently 9.1 days.
View CONMED's Short Interest
.

When is CONMED's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, January 25th 2023.
View our CNMD earnings forecast
.

How were CONMED's earnings last quarter?

CONMED Co. (NYSE:CNMD) issued its quarterly earnings data on Wednesday, October, 26th. The company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.75 by $0.02. The firm earned $275.09 million during the quarter, compared to the consensus estimate of $282.23 million. CONMED had a positive trailing twelve-month return on equity of 14.00% and a negative net margin of 7.74%.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED announced a quarterly dividend on Monday, December 5th. Investors of record on Friday, December 16th will be paid a dividend of $0.20 per share on Thursday, January 5th. This represents a $0.80 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend is Thursday, December 15th.
Read our dividend analysis for CNMD
.

Is CONMED a good dividend stock?

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.93%.
Read our dividend analysis for CNMD.

What guidance has CONMED issued on next quarter's earnings?

CONMED updated its FY 2023 earnings guidance on Tuesday, November, 15th. The company provided earnings per share (EPS) guidance of $3.20-$3.50 for the period, compared to the consensus estimate of $3.39. The company issued revenue guidance of $1.17 billion-$1.23 billion, compared to the consensus revenue estimate of $1.21 billion.

What is CONMED's stock symbol?

CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD."

Who are CONMED's major shareholders?

CONMED's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.77%), Vanguard Group Inc. (10.95%), State Street Corp (3.53%), Macquarie Group Ltd. (2.41%), Dimensional Fund Advisors LP (2.10%) and AXA S.A. (1.96%).

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CONMED's stock price today?

One share of CNMD stock can currently be purchased for approximately $87.00.

How much money does CONMED make?

CONMED (NYSE:CNMD) has a market capitalization of $2.65 billion and generates $1.01 billion in revenue each year. The company earns $62.54 million in net income (profit) each year or ($2.95) on an earnings per share basis.

How many employees does CONMED have?

The company employs 3,800 workers across the globe.

How can I contact CONMED?

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321.

This page (NYSE:CNMD) was last updated on 12/8/2022 by MarketBeat.com Staff